Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 26.47 percent increase over losses of $(0.34) per share from the same period last year.
Uncategorized
Aldeyra Therapeutics Q1 EPS $(0.25) Beats $(0.27) Estimate
Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 26.47 percent increase over losses of $(0.34) per share
Related Posts
Lake Street Initiates Coverage On Kimball Electronics with Buy Rating, Announces Price Target of $27
Lake Street analyst Jaeson Schmidt initiates coverage on Kimball Electronics (NASDAQ:KE) with a Buy rating and announces Price Target of $27.
Goldman Sachs Initiates Coverage On Accolade with Buy Rating, Announces Price Target of $32
Goldman Sachs analyst Cindy Motz initiates coverage on Accolade (NASDAQ:ACCD) with a Buy rating and announces Price Target of $32.
Preview: Discover Financial’s Earnings
Discover Financial (NYSE:DFS) is set to give its latest quarterly earnings report on Wednesday, 2022-07-20. Here's what investors need to know before the announcement.
Analysts estimate that Discover Financial will report an earnings per share (EPS) of $3.78.